Zwitterionic Hydrogel Sequesters Proteins for Bone Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current zwitterionic materials are primarily used for anti-biofouling and bioinert applications, with limited understanding of their ability to sequester and deliver ionic biomolecules in three-dimensional formats, restricting their utility in biomedical applications.
Innovation Solution
Zwitterionic networks are utilized to retain and deliver ionic biomolecules like proteins for guided tissue regeneration, leveraging their ability to sequester and sustain the bioactivity of proteins within a 3D crosslinked polymer network, which serves as a therapeutic delivery vehicle and tissue engineering scaffold.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If zwitterionic materials are used for anti-biofouling applications, then protein adsorption is suppressed, but the ability to sequester and deliver ionic biomolecules is not utilized
Solution Approach 1:
The zwitterionic hydrogel is designed to perform multiple functions: it maintains its anti-biofouling property to suppress non-specific protein adsorption while simultaneously gaining the ability to sequester and deliver ionic biomolecules through ionic interactions. This multi-functionality resolves the contradiction by making the material both bioinert and bioactive depending on the target molecule.
Solution Approach 2:
The hydrogel exhibits different interaction mechanisms for different types of molecules: it repels neutral proteins through hydrophilic effects while attracting and sequestering ionic biomolecules through electrostatic interactions with oppositely charged groups. This local differentiation of interaction quality allows simultaneous anti-fouling and delivery functions.
2Productivity
If conventional carriers are used for protein delivery, then delivery capability is achieved, but high doses are required resulting in increased cost and reduced safety
Solution Approach 1:
The zwitterionic hydrogel changes the interaction parameters between the carrier and therapeutic protein by introducing ionic groups that specifically bind ionic biomolecules. This enhances the binding affinity and delivery efficiency, allowing effective delivery at lower protein doses compared to conventional non-ionic carriers.
Solution Approach 2:
The hydrogel combines zwitterionic polymers with specific ionic groups to create a composite material that integrates both the structural framework for delivery and the ionic interaction sites for high-affinity binding, improving delivery efficiency while reducing required dose.
3Adaptability or versatility
If zwitterionic networks are used to sequester ionic biomolecules, then sequestration capability is enhanced, but the conventional perception of zwitterionic materials as purely anti-biofouling is challenged
Solution Approach 1:
The zwitterionic hydrogel provides dynamic control over biomolecule interactions, transitioning from passive anti-fouling to active sequestration and controlled release based on the ionic nature of the target biomolecule, demonstrating adaptable functionality rather than fixed behavior.
Solution Approach 2:
Instead of viewing zwitterionic materials solely through the lens of protein repulsion (anti-biofouling), the invention inverts the perspective to highlight their ability to attract and sequester oppositely charged ionic biomolecules, revealing a previously underappreciated functional dimension.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The zwitterionic hydrogel effectively sequesters and sustains the release of therapeutic proteins, such as rhBMP-2, promoting functional bone healing at significantly lower doses than conventional carriers, reducing costs and improving safety, while expanding the utility of zwitterionic materials in bioengineering and therapeutics.
Implementation Method 1
zwitterionic networks to sequester ionic biomacromolecules
Implementation Method 2
sustains the release of therapeutic proteins
Data Source
AI summary
The invention provides a novel approach in which zwitterionic networks are used to sequester and deliver ionic biomolecules, such as proteins, without compromising their native conformation and bioactivity. Zwitterionic networks are designed to effectively retain and deliver ionic or polar biomolecules for guided tissue regeneration. The invention represents a conceptual advance and enables a novel strategy for the utilization of zwitterionic motifs as therapeutics delivery vehicles and tissue engineering scaffolds.